May we track your activity on this site?

We use cookies and other trackers to monitor the effectiveness of our ad campaigns. You may withdraw your consent at any time by re-opening these options.

Program at a Glance

Click on each day to access the program.

LEGEND: Basic Science Clinical Science Public Health

* program subject to change without notice.

 

7:00AM
2:00PM
3:45PM
4:15PM
6:00PM
Thursday, June 14
CAHN Symposium 7:00AM‑3:30PM | Room 715 7:00AM - 8:00AM: BREAKFAST & WELCOME

8:00AM - 10:00AM: SESSION I: CLINICAL PEARLS - MODERATOR: KATHY POLDRE

9:45AM - 10:00AM: BREAK

10:00AM - 12:30PM: SESSION II: PRACTICE AND RESEARCH - MODERATOR: CHERYL DALE

11:40AM - 12:30PM: LUNCH

12:30PM - 2:15PM: SESSION III: EVOLUTION AND INNOVATION - MODERATOR: COLINA YIM

2:05PM - 2:15PM: BREAK

2:15PM - 3:30PM: SESSION IV:  PANEL DISCUSSION - MODERATOR: LESLEY GALLAGHER
Registration 7:00AM‑6:30PM | Level 600 GHS 2018 Welcome Address & Plenary 1: WHO Elimination Targets | Exhibit Hall G Gottfried Hirnschall - Elmination targets: Rationale and WHO's role in helping countries get there
David Thomas - What tools are needed to generate the evidence - measuring success
Su Wang - Role of patient and community in the global response
Greg Dore - National elimination in a focused epidemic: Australia
Manal El-Sayed - National elimination in a generalized epidemic: Egypt
Afternoon Break 3:45PM‑4:15PM HCV Virology | Room 714 Thomas Baumert - HCV infection and entry

Jane McKeating - Physiological Regulation of HCV Replication

Ralf Bartenschlager - HCV virion production and assembly

Oral Abstracts
New Biomarkers & Endpoints in HBV | Room 716 Henry Chan - The value of HBsAg quantification in the natural history and treatment of HBV

Jean Michel Pawlotsky - Choosing the right endpoint for HBV treatment

Harry Janssen - New Biomarkers for HBV infection

Oral Abstracts
HEV Pathogenesis & Treatment | Rom 715 Shiv Sarin - HEV and emerging worldwide pathogen?

Heiner Wedemeyer - Treatment of HEV infection

Ken Sherman - HEV in immunocompromised patients

Oral Abstracts
Pan American Symposium | Room 701 Alexandra King (Canada, CASL) - Effective Viral Hepatitis Control Strategies in Canadian Indigenous Populations
Merv Thomas (Canada, CASL) - Community Readiness: A critical component to viral hepatitis control
Brian McMahon (US, AASLD) - Control of hepatitis B and its consequences in the Alaskan Native population
Jorge Mera (US, AASLD) - The Cherokee Elimination Project
Martin Tagle (Latin America, ALEH) - The challenge of viral hepatitis in the Andes
Raymundo Parana (Latin America, ALEH) - Addressing viral hepatitis - HBV & HDV - in the Amazon basin
Nick Walsh (US, WHO) - Efforts from PAHO to address viral hepatitis in Indigenous communities in the Americas
Exhibits, Posters & Welcome Reception 6:00PM‑8:00PM | Exhibit Hall F